Sharon Nofech‐Mozes

5.1k total citations
152 papers, 3.0k citations indexed

About

Sharon Nofech‐Mozes is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Sharon Nofech‐Mozes has authored 152 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Cancer Research, 61 papers in Oncology and 38 papers in Pathology and Forensic Medicine. Recurrent topics in Sharon Nofech‐Mozes's work include Breast Cancer Treatment Studies (55 papers), Breast Lesions and Carcinomas (33 papers) and Endometrial and Cervical Cancer Treatments (31 papers). Sharon Nofech‐Mozes is often cited by papers focused on Breast Cancer Treatment Studies (55 papers), Breast Lesions and Carcinomas (33 papers) and Endometrial and Cervical Cancer Treatments (31 papers). Sharon Nofech‐Mozes collaborates with scholars based in Canada, United States and Egypt. Sharon Nofech‐Mozes's co-authors include Wedad Hanna, Nadia Ismiil, Eileen Rakovitch, Zeina Ghorab, Mahmoud A. Khalifa, Anne L. Martel, Steven A. Narod, John M.S. Bartlett, Jane Bayani and Joema Felipe Lima and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sharon Nofech‐Mozes

147 papers receiving 3.0k citations

Peers

Sharon Nofech‐Mozes
David N. Church United Kingdom
Fei Dong United States
Zaibo Li United States
Fanny Dao China
J. P. A. Baak Netherlands
David N. Church United Kingdom
Sharon Nofech‐Mozes
Citations per year, relative to Sharon Nofech‐Mozes Sharon Nofech‐Mozes (= 1×) peers David N. Church

Countries citing papers authored by Sharon Nofech‐Mozes

Since Specialization
Citations

This map shows the geographic impact of Sharon Nofech‐Mozes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Nofech‐Mozes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Nofech‐Mozes more than expected).

Fields of papers citing papers by Sharon Nofech‐Mozes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Nofech‐Mozes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Nofech‐Mozes. The network helps show where Sharon Nofech‐Mozes may publish in the future.

Co-authorship network of co-authors of Sharon Nofech‐Mozes

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Nofech‐Mozes. A scholar is included among the top collaborators of Sharon Nofech‐Mozes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Nofech‐Mozes. Sharon Nofech‐Mozes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Srinidhi, Chetan L., et al.. (2025). Artificial Intelligence–Assisted Detection of Breast Cancer Lymph Node Metastases in the Post-Neoadjuvant Treatment Setting. Laboratory Investigation. 105(6). 104121–104121.
2.
Rizvi, Naiyer A., Eliseos J. Mucaki, Monica Zhang, et al.. (2025). Mutational landscape of pure ductal carcinoma in situ and associations with disease prognosis and response to radiotherapy. Breast Cancer Research. 27(1). 127–127.
3.
Olkhov‐Mitsel, Ekaterina, Danny Chan, Kenneth J. Craddock, et al.. (2024). Analytical Validation and Performance Evaluation of Amplicon-Based Next-Generation Sequencing Assays for Detecting ERBB2 and Other Gene Amplifications in Solid Tumors. Cancers. 16(23). 3927–3927. 1 indexed citations
4.
Hahn, Ezra, Rinku Sutradhar, Danielle Rodin, et al.. (2024). Molecular Expression Assays Improve the Prediction of Local and Invasive Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ. Journal of Clinical Oncology. 42(27). 3196–3206. 2 indexed citations
5.
Plotkin, Anna, Ekaterina Olkhov‐Mitsel, & Sharon Nofech‐Mozes. (2023). MLH1 Methylation Testing as an Integral Component of Universal Endometrial Cancer Screening—A Critical Appraisal. Cancers. 15(21). 5188–5188. 2 indexed citations
6.
Hahn, Ezra, Danielle Rodin, Rinku Sutradhar, et al.. (2023). Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?. Current Oncology. 30(6). 5795–5806. 5 indexed citations
7.
Olkhov‐Mitsel, Ekaterina, Aurelia Busca, Carlos Parra‐Herran, et al.. (2023). Genomic profiling of dedifferentiated endometrial carcinomas arising in the background of high‐grade carcinoma: a targeted next‐generation sequencing study. Histopathology. 83(3). 366–375. 2 indexed citations
8.
Fan, Kevin Yijun, Rania Chehade, Maleeha Qazi, et al.. (2023). Androgen Receptor Is Expressed in the Majority of Breast Cancer Brain Metastases and Is Subtype-Dependent. Cancers. 15(10). 2748–2748. 4 indexed citations
9.
Kozak, Robert, Sharon Nofech‐Mozes, Ekaterina Olkhov‐Mitsel, et al.. (2023). Cystic neutrophilic granulomatous mastitis: sensitivity and specificity of 16s rRNA and Sanger sequencing for Corynebacterium spp. Journal of Clinical Pathology. 77(5). 306–311. 4 indexed citations
10.
Rakovitch, Eileen, Rinku Sutradhar, Sharon Nofech‐Mozes, et al.. (2020). 21-Gene Assay and Breast Cancer Mortality in Ductal Carcinoma In Situ. JNCI Journal of the National Cancer Institute. 113(5). 572–579. 13 indexed citations
11.
Zyla, Roman, Lilian T. Gien, Danielle Vicus, et al.. (2020). The prognostic role of horizontal and circumferential tumor extent in cervical cancer: Implications for the 2019 FIGO staging system. Gynecologic Oncology. 158(2). 266–272. 6 indexed citations
12.
Morgan, Sarah, Yutaka Amemiya, Elzbieta Slodkowska, et al.. (2019). Pilot Study on the Utility of Circulating HER2/Neu Levels in the Serum of Breast Cancer Patients. Anticancer Research. 39(10). 5345–5352. 2 indexed citations
13.
Raphael, Jacques, Alex Kiss, Sharon Nofech‐Mozes, & Maureen Trudeau. (2018). Clinical Outcomes of Single Versus Double Hormone Receptor–Positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. Clinical Breast Cancer. 18(6). e1381–e1387. 7 indexed citations
14.
Slodkowska, Elzbieta, Sharon Nofech‐Mozes, Bin Xu, et al.. (2018). Fibroepithelial lesions of the breast: a comprehensive morphological and outcome analysis of a large series. Modern Pathology. 31(7). 1073–1084. 30 indexed citations
15.
Cox, Courtney, et al.. (2013). What is the Burden of Axillary Disease after Neoadjuvant Therapy in Women with Locally Advanced Breast Cancer?. Current Oncology. 20(2). 111–117. 4 indexed citations
16.
Helpman, Limor, Rachel Kupets, Al Covens, et al.. (2013). Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer. British Journal of Cancer. 110(3). 609–615. 78 indexed citations
17.
Han, Kathy, Sharon Nofech‐Mozes, Steven A. Narod, et al.. (2011). Expression of HER2neu in Ductal Carcinoma in situ is Associated with Local Recurrence. Clinical Oncology. 24(3). 183–189. 43 indexed citations
18.
Nofech‐Mozes, Sharon, Maureen Trudeau, Rebecca Dent, et al.. (2009). Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers. Breast Cancer Research and Treatment. 118(1). 131–137. 84 indexed citations
19.
Nofech‐Mozes, Sharon, Robert G. MacKenzie, Harriette J. Kahn, Lisa Ehrlich, & Simon Raphael. (2007). Breast metastasis by medullary thyroid carcinoma detected by FDG positron emission tomography. Annals of Diagnostic Pathology. 12(1). 67–71. 8 indexed citations
20.
Nofech‐Mozes, Sharon, Golnar Rasty, Nadia Ismiil, Allan Covens, & Mohamed Ali Khalifa. (2006). Immunohistochemical characterization of endocervical papillary serous carcinoma. International Journal of Gynecological Cancer. 16(S1). 286–292. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026